Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells

  • Authors:
    • P. G. Mitlianga
    • A. P. Kyritsis
    • C. Gomez-Manzano
    • M. G. Lemoine
    • M. Hu
    • T.-J. Liu
    • W. K.A. Yung
    • J. Fueyo
  • View Affiliations

  • Published online on: February 1, 2001     https://doi.org/10.3892/ijo.18.2.343
  • Pages: 343-347
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gliomas are highly resistant to conventional treatment. Improved knowledge of the molecular defects of glioma cells offers new avenues for the development of gene therapy strategies. Transfer of the p53 gene has proven effective in suppressing proliferation in human glioma cell lines. However, several human glioma cell lines are resistant to p53-induced cell death. The E2F family of transcription factors are pivotal for the regulation of cell-cycle and cell-death related genes in gliomas. In the present study, we sought a more effective strategy for glioma treatment by examining the therapeutic potential of the simultaneous transfer of p53 and E2F-2 to gliomas. Trypan blue cell viability assays and flow cytometric cell-cycle analysis demonstrated that the transfer of both p53 and E2F-2 induced cell death in D-54 MG, a p53-resistant glioma cell line. In addition, transfer of E2F-2 did not interfere with the apoptotic properties of exogenous wild-type p53 in U-251 MG cells. Finally, the expression of E2F-2 in D-54 MG cells suppressed the expression of the apoptotic molecule mdm-2 induced by exogenous p53 in these cells. These results show that co-expression of E2F-2 and p53 enhances the anti-cancer effect of p53 in gliomas.

Related Articles

Journal Cover

February 2001
Volume 18 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mitlianga PG, Kyritsis AP, Gomez-Manzano C, Lemoine MG, Hu M, Liu T, Yung WK and Fueyo J: Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. Int J Oncol 18: 343-347, 2001.
APA
Mitlianga, P.G., Kyritsis, A.P., Gomez-Manzano, C., Lemoine, M.G., Hu, M., Liu, T. ... Fueyo, J. (2001). Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. International Journal of Oncology, 18, 343-347. https://doi.org/10.3892/ijo.18.2.343
MLA
Mitlianga, P. G., Kyritsis, A. P., Gomez-Manzano, C., Lemoine, M. G., Hu, M., Liu, T., Yung, W. K., Fueyo, J."Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells". International Journal of Oncology 18.2 (2001): 343-347.
Chicago
Mitlianga, P. G., Kyritsis, A. P., Gomez-Manzano, C., Lemoine, M. G., Hu, M., Liu, T., Yung, W. K., Fueyo, J."Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells". International Journal of Oncology 18, no. 2 (2001): 343-347. https://doi.org/10.3892/ijo.18.2.343